Skip to main content
. 2020 Jul 20;21(14):5137. doi: 10.3390/ijms21145137

Figure 5.

Figure 5

Effects of ruxolitinib treatment on hair-growth-related growth factors. Ruxolitinib significantly upregulated the mRNA of various growth factors including (A) FGF2, (B) FGF7, (C) IGF1, (D) PDGF, and (E) VEGF, which was suppressed by IFN-γ. The data represent the means ± SEM, n = 3, statistically significant at * p < 0.05, ** p < 0.01, *** p < 0.001, compared to the control and # p < 0.05, ## p < 0.01, ### p < 0.001 compared to the IFN-γ-treated group.